AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: BRTX
Report Date: 2026-05-26
Full Report: https://amaly.io/stock/BRTX

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: BRTX, a biotechnology company in an unknown industry, exhibits strong compliance in debt (0%) and non-permissible income (0%) ratios but fails significantly in liquidity (63.58%) and interest income (642.35%) metrics, leading to non-compliance across major Shariah standards. The core business in regenerative medicine is permissible, with no non-compliant activities identified. However, financial anomalies due to low revenue amplify riba exposure. Index exclusion confirms overall non-compliance, though purification is required for any incidental income. Investors should monitor for improvements in revenue generation to reduce ratio distortions.

Primary Compliance Concerns:
- Liquidity ratio exceeds thresholds across AAOIFI, MSCI, and S&P standards
- Interest income ratio significantly above 5% limit, indicating high riba exposure

Purification Requirement: 642.35%
Index Inclusion: Excluded from all major Shariah indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 63.6%
Interest Income Ratio: 642.4%
Purification Required: 0.00%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-11-30

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-21T12:00:00Z

---
Full interactive report: https://amaly.io/stock/BRTX
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.